Please assess the completion status of the following clinical trial:

Trial Title: mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosed with HIV/AIDS~2. Over the age of 18 years~3. Able to provide written informed consent~4. Able to communicate in English~5. Health literacy level of marginal or inadequate (as measured by the Newest Vital Sign (NVS): total score of 3 or lower)~6. Report at least 2 HIV related adverse symptoms in the past week~7. Owner of a smart phone/tablet.~Exclusion Criteria:~1. Inability to communicate in English~2. Documented diagnosis of dementia~3. Pregnancy~4. Unable to understand consent procedure~5. Self-reporting no adverse symptoms within the past week. (HIV-related symptoms include: anxiety, constipation, cough, depression, diarrhea, dizziness, fever, forgetfulness, fatigue, nausea, night sweats, neuropathy, shortness of breath, dermatitis, swelling of arms, hand, legs, feet, insomnia, weight loss, oral thrush, and vaginal itching, burning and discharge)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- mVIP group (Type: EXPERIMENTAL): This group will receive targeted symptom strategies via a Health Management App developed from the UCSF symptom management manual based on the symptoms that they report. This is the intervention app group.
- Attention Control Group (Type: PLACEBO_COMPARATOR): This group will received an app without symptom strategies, pre-loaded on their smartphones. This is the control app group.

Based on this trial design, predict the completion outcome and termination type (if applicable).